MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation
Nucleic Acids Research · 05.07.2024 · 52 (W1) · W398-W406
DOI: 10.1093/nar/gkae253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 08.04.2024. Verfasst von Zhiqiang Pang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada. Hauptthemen laut MEDLINE: Metabolomics, Software, Algorithms, Tandem Mass Spectrometry. Die Arbeit wurde bisher 2598-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Genome Canada, NCI NIH HHS.
Abstract (Originalsprache)
We introduce MetaboAnalyst version 6.0 as a unified platform for processing, analyzing, and interpreting data from targeted as well as untargeted metabolomics studies using liquid chromatography - mass spectrometry (LC–MS). The two main objectives in developing version 6.0 are to support tandem MS (MS2) data processing and annotation, as well as to support the analysis of data from exposomics studies and related experiments. Key features of MetaboAnalyst 6.0 include: (i) a significantly enhanced Spectra Processing module with support for MS2 data and the asari algorithm; (ii) a MS2 Peak Annotation module based on comprehensive MS2 reference databases with fragment-level annotation; (iii) a new Statistical Analysis module dedicated for handling complex study design with multiple factors or phenotypic descriptors; (iv) a Causal Analysis module for estimating metabolite - phenotype causal relations based on two-sample Mendelian randomization, and (v) a Dose-Response Analysis module for benchmark dose calculations. In addition, we have also improved MetaboAnalyst's visualization functions, updated its compound database and metabolite sets, and significantly expanded its pathway analysis support to around 130 species. MetaboAnalyst 6.0 is freely available at https://www.metaboanalyst.ca.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.
- Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
- Department of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.
- Departments of Biological Sciences and Computing Science, University of Alberta, Edmonton, Alberta, Canada.
- The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
- University of Connecticut School of Medicine, Farmington, CT, USA.
ORCID-Profile: Jianguo Xia
Förderung
- CIHR
- Genome Canada
- NCI NIH HHS
- Diabetes Canada
- Natural Sciences and Engineering Research Council of Canada
- Juvenile Diabetes Research Foundation
- CFI
- US National Institutes of Health
Zitieren
APA
Pang, Z., Lu, Y., Zhou, G., Hui, F., Xu, L., Viau, C., Spigelman, A. F., MacDonald, P. E., Wishart, D. S., Li, S., & Xia, J. (2024). MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Research, 52(W1), W398-W406. https://doi.org/10.1093/nar/gkae253
Vancouver
Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Research. 2024;52(W1):W398-W406. doi:10.1093/nar/gkae253
BibTeX
@article{Pang2024,
author = {Pang, Zhiqiang and Lu, Yao and Zhou, Guangyan and Hui, Fiona and Xu, Lei and Viau, Charles and Spigelman, Aliya F and MacDonald, Patrick E and Wishart, David S and Li, Shuzhao and Xia, Jianguo},
title = {MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {W1},
pages = {W398--W406},
doi = {10.1093/nar/gkae253}
}
EUVIMED